Clinical trials: Daptomycin
Healthy
Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China
The primary objective of this study is to characterise the pharmacokinetics and dose proportionality of daptomycin after single and multiple (once daily) 4mg/kg and 6 mg/kg doses of daptomycin in healthy Chinese volunteers.
- Trial name
- NCT00858325
- Testing
- Daptomycin
- Where
- China
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- AstraZeneca